Clotting of blood is actually the body’s protective mechanism aimed at arresting bleeding and minimizing blood loss in the event of serious injuries and accidents.
Without efficient blood clotting processes, the risk of severe blood loss can increase substantially.
However, blood clotting is a double-edged weapon as when the same clots are formed inside the bloodstream, they may clog the arteries interrupting the blood supply to vital organs like the heart and the brain.
This can increase the risk of heart attacks and stroke, respectively.
Several research studies have been conducted to assess the influence of height on the risk of developing disorders related to the clotting of blood.
There is no clinical evidence proving the influence of height on the risk of developing bleeding or clotting disorders in adults.
Abnormal bleeding in children
However, some studies have shown that children might be at risk of some types of bleeding disorders based on the variations in their height.
Link between height and Hemophilia
One study has shown that children diagnosed with Hemophilia are more likely to have stunted or slower growth. Hemophilia is a rare disorder that could be genetically linked. It occurs because of the absence of clotting factors due to which the blood does not clot when there is a need.
Hemophilia patients are often treated with inhibitors that inhibit or block the activities of factors that can otherwise bind to and destroy these clotting factors making them unavailable and less efficient to clot the blood.
Studies that evaluated skeletal maturation, height velocity, serum testosterone levels, and stature in patients with Hemophilia have revealed the link between height and blood clotting.
It was found that the bone age in patients who were treated with inhibitors lagged behind by nearly 9 months. This impact was observed in Hemophilia patients between the ages of 12 to 15 years. 
Those with a history of using inhibitors attained a lower growth velocity. The serum testosterone levels were also significantly lower in these patients.
The results of this investigation have shown that Hemophilia patients are more likely to have a shorter height when they grow into adulthood, especially when they have been treated with inhibitors.